首页 | 官方网站   微博 | 高级检索  
     

无细胞百白破疫苗加强免疫的安全性和免疫原性研究
引用本文:侯启明,杨景芳.无细胞百白破疫苗加强免疫的安全性和免疫原性研究[J].粉末涂料与涂装,1995,8(3):135-139.
作者姓名:侯启明  杨景芳
摘    要:经无细胞百白破(APDT)或全细胞百白破疫苗(WPDT)基础免疫的儿童,一年后分三个组,进行加强免疫,观察其安全性和有效性。结果表明:APDT组和W.APDT组的局部和全身反应低于WPDT组,而且差异显著(P<0.05);抗-PT和抗-FHA的水平明显高于WPDT组(P<0.01)。加强免疫后抗体增长的程度与基础免疫所用疫苗类型无关。三个试验组皆能产生高滴度的白喉和破伤风抗体。

关 键 词:无细胞百白破  安全性  免疫原性

Safety and Immunogenicity of Booster Immunizzation with Acellular DPT Vaccine
Hou Qiming et al.Safety and Immunogenicity of Booster Immunizzation with Acellular DPT Vaccine[J].Chinese Journal of Biologicals,1995,8(3):135-139.
Authors:Hou Qiming
Abstract:The children who received acellular DPT (APDT) one year ago were adminis-tered with a booster of APDT (group 1), howrver, those who received whole cell DPT(WPDT) were divided into 2 groups and a booster injection were given with APDT (group2) and WPDT (group 3) respectively. Then the safety and immunogencity of the 3 groupswere observed. The result showed that the local and systemic reaction rates, as well as anti-PT and anti-FHA levels of group 1 and 2 were significantly higher than those of group 3.There was no correlation between the anti - PT and anti - FHA increasing levels and thesorts of vaccines used of the primary immunization. For diphtheria and tetans, high antibodytiters were observed in all the 3 groups.
Keywords:APDT Booster immunization Safety Immunogenicity
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号